Ras GTPase: Difference between revisions

Latest revision as of 15:17, 9 December 2024

File:Hras secondary structure ribbon.png

An overview of Ras GTPase, its function, and significance in cellular processes

Ras GTPase is a family of proteins involved in transmitting signals within cells (cellular signal transduction). These proteins are a subfamily of the small GTPase superfamily and play a crucial role in the regulation of cell division, differentiation, and survival. Ras proteins are often referred to as molecular switches because they cycle between an active GTP-bound state and an inactive GDP-bound state.

Structure and Function[edit]

Ras proteins are small, approximately 21 kDa, and are composed of a single polypeptide chain. They have a highly conserved structure that includes a GTP-binding domain and a C-terminal hypervariable region that undergoes post-translational modifications, such as prenylation, which is essential for their membrane localization and function.

GTPase Activity[edit]

Ras proteins possess intrinsic GTPase activity, which allows them to hydrolyze GTP to GDP. This activity is crucial for their function as molecular switches. In their GTP-bound form, Ras proteins are active and can interact with various downstream effectors to propagate signaling pathways. The conversion to the GDP-bound form inactivates Ras, terminating the signal.

Regulation[edit]

Ras activity is tightly regulated by two main types of regulatory proteins:

Guanine nucleotide exchange factors (GEFs): These proteins facilitate the exchange of GDP for GTP, activating Ras.
GTPase-activating proteins (GAPs): These proteins enhance the intrinsic GTPase activity of Ras, promoting the hydrolysis of GTP to GDP and inactivating Ras.

Role in Signal Transduction[edit]

Ras proteins are key players in several signaling pathways, most notably the MAPK/ERK pathway. Upon activation by upstream signals, such as growth factors binding to receptor tyrosine kinases, Ras activates a cascade of kinases that ultimately lead to changes in gene expression and cellular responses.

Clinical Significance[edit]

Mutations in Ras genes, such as HRAS, KRAS, and NRAS, are implicated in various human cancers. These mutations often result in constitutively active Ras proteins that drive uncontrolled cell proliferation and survival, contributing to oncogenesis. KRAS mutations are particularly common in pancreatic cancer, colorectal cancer, and non-small cell lung cancer.

Research and Therapeutic Approaches[edit]

Given the role of Ras in cancer, it is a significant target for therapeutic intervention. However, directly targeting Ras has been challenging due to its high affinity for GTP/GDP and the lack of suitable binding pockets for small molecules. Recent advances include the development of inhibitors targeting specific mutant forms of Ras, such as KRAS G12C inhibitors.

Also see[edit]

@@ Line 1: / Line 1: @@
-{{Infobox protein
+[[File:Hras secondary structure ribbon.png|thumb]] [[File:Signal transduction pathways.svg|thumb]] {{Short description|An overview of Ras GTPase, its function, and significance in cellular processes}}
-| name = Ras GTPase
-| image = Ras protein.png
-| caption = Structure of Ras GTPase
-| symbol = RAS
-| pdb = 5P21
-}}
-'''Ras GTPase''' is a family of proteins involved in transmitting signals within cells (cellular signal transduction). These proteins are a subfamily of the small GTPase superfamily and are involved in various cellular processes, including growth, differentiation, and survival. Ras proteins are often referred to as molecular switches because they cycle between an active GTP-bound state and an inactive GDP-bound state.
+'''Ras GTPase''' is a family of proteins involved in transmitting signals within cells (cellular signal transduction). These proteins are a subfamily of the small GTPase superfamily and play a crucial role in the regulation of cell division, differentiation, and survival. Ras proteins are often referred to as molecular switches because they cycle between an active GTP-bound state and an inactive GDP-bound state.
-==Structure==
+==Structure and Function==
-Ras proteins are small, approximately 21 kDa, and consist of a single polypeptide chain. They have a highly conserved structure that includes a GTP-binding domain and a C-terminal hypervariable region. The GTP-binding domain is responsible for the protein's ability to bind and hydrolyze GTP, while the hypervariable region is involved in membrane localization and interaction with other proteins.
+Ras proteins are small, approximately 21 kDa, and are composed of a single polypeptide chain. They have a highly conserved structure that includes a GTP-binding domain and a C-terminal hypervariable region that undergoes post-translational modifications, such as prenylation, which is essential for their membrane localization and function.
-==Function==
+===GTPase Activity===
-Ras proteins play a crucial role in the [[MAPK/ERK pathway]], which is a key signaling pathway that regulates cell division, differentiation, and apoptosis. When Ras is activated by binding to GTP, it interacts with and activates a series of downstream effectors, including [[Raf kinase]], [[PI3K]], and [[RalGDS]]. These interactions lead to the activation of various signaling cascades that ultimately result in changes in gene expression and cellular behavior.
+Ras proteins possess intrinsic GTPase activity, which allows them to hydrolyze GTP to GDP. This activity is crucial for their function as molecular switches. In their GTP-bound form, Ras proteins are active and can interact with various downstream effectors to propagate signaling pathways. The conversion to the GDP-bound form inactivates Ras, terminating the signal.
-==Regulation==
+===Regulation===
-Ras activity is tightly regulated by two main types of proteins: [[guanine nucleotide exchange factors]] (GEFs) and [[GTPase-activating proteins]] (GAPs). GEFs promote the exchange of GDP for GTP, thereby activating Ras, while GAPs increase the intrinsic GTPase activity of Ras, leading to its inactivation.
+Ras activity is tightly regulated by two main types of regulatory proteins:
+* '''Guanine nucleotide exchange factors (GEFs)''': These proteins facilitate the exchange of GDP for GTP, activating Ras.
+* '''GTPase-activating proteins (GAPs)''': These proteins enhance the intrinsic GTPase activity of Ras, promoting the hydrolysis of GTP to GDP and inactivating Ras.
+==Role in Signal Transduction==
+Ras proteins are key players in several signaling pathways, most notably the [[MAPK/ERK pathway]]. Upon activation by upstream signals, such as growth factors binding to receptor tyrosine kinases, Ras activates a cascade of kinases that ultimately lead to changes in gene expression and cellular responses.
 ==Clinical Significance==
-Mutations in Ras genes are among the most common genetic alterations in human cancers. These mutations often result in constitutively active Ras proteins that drive uncontrolled cell proliferation and tumorigenesis. The most frequently mutated Ras genes in cancer are [[HRAS]], [[KRAS]], and [[NRAS]]. Targeting Ras signaling pathways is a major focus of cancer research and drug development.
+Mutations in Ras genes, such as [[HRAS]], [[KRAS]], and [[NRAS]], are implicated in various human cancers. These mutations often result in constitutively active Ras proteins that drive uncontrolled cell proliferation and survival, contributing to oncogenesis. KRAS mutations are particularly common in [[pancreatic cancer]], [[colorectal cancer]], and [[non-small cell lung cancer]].
-==History==
+==Research and Therapeutic Approaches==
-The Ras gene was first identified in the early 1980s as an oncogene in rat sarcoma virus. Subsequent research revealed its role in normal cellular signaling and its involvement in human cancers. The discovery of Ras and its function in cell signaling has been pivotal in understanding the molecular basis of cancer.
+Given the role of Ras in cancer, it is a significant target for therapeutic intervention. However, directly targeting Ras has been challenging due to its high affinity for GTP/GDP and the lack of suitable binding pockets for small molecules. Recent advances include the development of inhibitors targeting specific mutant forms of Ras, such as KRAS G12C inhibitors.
 ==Also see==
 * [[MAPK/ERK pathway]]
-* [[GTPase-activating protein]]
+* [[GTPase]]
-* [[Guanine nucleotide exchange factor]]
 * [[Oncogene]]
 * [[Signal transduction]]
+* [[Cancer biology]]
-{{Protein-stub}}
 {{Signal transduction}}
+{{Oncogenes}}
 [[Category:Signal transduction]]
 [[Category:Oncogenes]]
 [[Category:GTPases]]